Sequential high dose chemotherapy as initial treatment for aggressive sub-types of non-Hodgkin lymphoma: results of the international randomized phase III trial (MISTRAL).

Source:http://linkedlifedata.com/resource/pubmed/id/16888080

Download in:

View as

General Info

PMID
16888080